A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

  • Raison C
  • Rutherford R
  • Woolwine B
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Charles Raison

  • Robin Rutherford

  • Bobbi Woolwine

  • Chen Shuo

  • Pamela Schettler

  • Daniel Drake

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free